Search Results

QT Interval Prolongation: Preclinical and Clinical Testing Arrhythmogenesis in Drugs and Regulatory Implications

Authors: Giorgi, Mariano A.; Bolanos, Ricardo; Gonzalez, Claudio D.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 54-57(4)

Publisher: Bentham Science Publishers

Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors

Authors: Keller, Guillermo A.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 73-78(6)

Publisher: Bentham Science Publishers

FDA warns of clopidogrel/omeprazole interaction

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 1-1(1)

Publisher: Adis International

Natalizumab [Tysabri] is undergoing a benefit-risk review

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 2-2(1)

Publisher: Adis International

More dietary supplements recalled

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 2-2(1)

Publisher: Adis International

An update on safety of Gardasil from Denmark

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 5-5(1)

Publisher: Adis International

Byetta label changed to include renal failure warnings

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 5-5(1)

Publisher: Adis International

NHS must do more to prevent patient harm

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 5-5(1)

Publisher: Adis International

Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies

Authors: Tesmoingt, Chloe; Lidove, Olivier; Reberga, Axele; Thetis, Marguerite; Ackaert, Chloe; Nicaise, Pascale; Arnaud, Philippe; Papo, Thomas

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 765-769(5)

Publisher: Blackwell Publishing

Safety profiles for oseltamivir and zanamivir remain positive

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Nebulisers not an option with Relenza dry powder

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Prevnar batch suspended after three infant deaths

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Hospira have voluntarily recalled certain lots of propofol and Liposyn [soya oil emulsion]

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

MHRA November update

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Bisphosphonates and the risk of ONJ

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Janssen-Cilag International NV, in collaboration with EMEA, have issued a `Dear Healthcare Professional' letter

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Body building dietary supplements found to contain steroids

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

A `dietary supplement' marketed for sexual enhancement has been found to illegally contain an undeclared pharmaceutical agent

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

Certain lots of Tylenol [paracetamol, acetaminophen] Arthritis Pain Caplets are being voluntarily recalled in the US.

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

The product label for Optimark [gadoversetamide] is being modified

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International